Linear Source Registry for Prostate Cancer (CaRePC)

CivaTech Oncology

Status: Completed

Conditions: Prostate Cancer

Treatments: Radiation: Linear LDR Source

Study type: Observational

Funder types: Industry

Identifiers

NCT02516709

CT003

Details and patient eligibility

About

Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.

Full description

This registry is being conducted to provide long term analysis on the use of the linear Civastring source for prostate cancer. Prospective data collection will record and demonstrate biochemical response rates. Long term side effects and adverse events will be monitored.

Enrollment: 60 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years old
• Plans to remain in care of enrolling physician for 5 years
• > 5 years life expectancy
• Signed informed consent
• Enrolled within 6 weeks of implant or within 365 days of prior implant

Exclusion criteria

• Not willing or able to comply with protocol visit schedule